仟源医药(300254) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 reached ¥238,477,452.79, representing a year-on-year increase of 14.82%[5] - Net profit attributable to shareholders was ¥21,946,557.84, a significant increase of 106.06% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,538,701.88, up 212.36% year-on-year[5] - The total operating revenue for the current period is ¥611,473,385.33, slightly up from ¥608,815,610.55 in the previous period, indicating a growth of approximately 0.27%[23] - Net profit for the current period was ¥48,470,797.18, down from ¥67,158,532.63, representing a decline of about 28%[25] - The total profit increased to ¥77,369,333.81 from ¥73,407,341.08, an increase of approximately 4.1%[24] - Basic earnings per share decreased to ¥0.0922 from ¥0.1827, a decline of about 49%[25] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥1,549,765,358.12, reflecting a slight increase of 0.13% from the end of the previous year[5] - Total assets amounted to ¥1,549,765,358.12, a slight increase from ¥1,547,725,078.17, indicating a growth of approximately 0.07%[21] - Total liabilities increased to ¥972,673,007.61 from ¥949,545,094.09, representing a rise of about 2.42%[21] - The company's equity attributable to shareholders decreased to ¥294,207,395.41 from ¥342,998,882.45, a decline of approximately 14.26%[21] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥75,411,853.86, an increase of 19.56% compared to the previous year[9] - Operating cash flow net amount increased to ¥75,411,853.86 from ¥63,071,990.33, an increase of approximately 19%[28] - Cash and cash equivalents decreased to ¥128,975,832.88 from ¥149,518,040.96, representing a decline of about 13.73%[19] - Cash and cash equivalents at the end of the period decreased to ¥128,964,832.88 from ¥176,467,322.01, a decline of about 27%[29] - Investment activities resulted in a net cash flow of -¥88,810,515.70, worsening from -¥59,371,258.67[28] - Financing activities generated a net cash flow of -¥7,143,546.24, compared to a positive cash flow of ¥40,774,022.37 in the previous period[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 24,916[11] - The top 10 shareholders hold a total of 56,000,000 shares, with Zhao Qun and Huang Lequn each holding 6.16% of the shares[11] - Zhao Qun has 15,781,792 shares, of which 11,836,344 are subject to lock-up restrictions[13] - The total number of restricted shares at the end of the reporting period is 30,424,393, with 9,439,925 shares added during the period[14] - The company has a stock incentive plan that allows for 25% of restricted shares to be unlocked annually starting in 2024[13] - The company held a board meeting to approve the 2025 stock incentive plan and related amendments[15] - The company has 204 core technical and key personnel with a total of 10,400,000 restricted shares under the incentive plan[14] - The top shareholder, Zhao Qun, has a total of 10,276,419 restricted shares at the beginning of the period[13] - The company has not disclosed any related party relationships among the top shareholders[11] Expenses and Costs - Financial expenses for the year-to-date were ¥17,522,800.00, an increase of 50.80% compared to the same period last year, mainly due to higher bank loan interest[9] - The company reported a decrease in other income by 62.88% year-on-year, amounting to ¥3,433,400.00, primarily due to reduced government subsidies received[9] - Total operating costs decreased from ¥563,187,725.70 to ¥552,167,468.27, a reduction of approximately 1.8%[24] - The company reported a tax expense of ¥28,898,536.63, significantly higher than ¥6,248,808.45 in the previous period[24] Other Information - The balance of construction in progress increased by 149.71% year-on-year, reaching ¥38,165,100.00, due to new factory renovation projects[8] - The balance of prepaid expenses increased by 51.33% year-on-year, totaling ¥4,323,600.00, primarily due to increased advance payments for goods[8] - The company's independent director Gao Hao resigned during the reporting period[15]